Cortexyme competitorsClear all
Cortexyme's top competitors include Alector, Aimmune Therapeutics and Portola Pharmaceuticals.
| Save Comparison |  Cortexyme Cortexyme is a biopharmaceutical company developing therapeutics for Alzheimer's disease and other degenerative disorders. |  Alector Alector is a clinical-stage biopharmaceutical company that develops therapies for the treatment of neurodegenerative diseases. |  Aimmune Therapeutics Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other food allergies. | |
Founding Date | Founding Date 2012 | Founding Date 2013 | Founding Date 2011 | Founding Date 2003 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations San Francisco, US HQ | Locations South San Francisco, US HQ Milpitas, US | Locations Brisbane, US HQ München, DE Dublin, IE London, GB Durham, US | Locations South San Francisco, US HQ Krailling, DE Amsterdam, NL |
Employees | Employees 2321% increase | Employees 1264% increase | Employees 2755% increase | Employees 32429% increase |
Valuation ($) | Valuation ($) 961.9 m | Valuation ($) 1.3 b | Valuation ($) 2.3 b | Valuation ($) 1.4 b |
Twitter followers | Twitter followers 311 | Twitter followers N/A | Twitter followers 1.6 k | Twitter followers 951 |
Alexa Website Rank | Alexa Website Rank 427855 | Alexa Website Rank 302916 | Alexa Website Rank 193253 | Alexa Website Rank 251077 |
Employee Rating | Employee Rating N/A | Employee Rating N/A | Employee Rating 4.3 | Employee Rating 3.4 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $21.2m (FY, 2019) | Revenue (est.) N/A | Revenue (est.) $116.6m (FY, 2019) |
Net income | Net income ($37m) (FY, 2019) | Net income ($105.4m) (FY, 2019) | Net income ($248.5m) (FY, 2019) | Net income ($290.7m) (FY, 2019) |
Funding | ||||
Total funding raised | Total funding raised $ 100m | Total funding raised $ 194.5m | Total funding raised $ 145m | Total funding raised $ 295.1m |
For sources of this data, please see the company profile
View company profiles
Alector
HQ
South San Francisco, US
Employees
126↑ 4% increase
Alector is a clinical-stage biopharmaceutical company that develops therapies for the treatment of neurodegenerative diseases.
View companyAimmune Therapeutics
HQ
Brisbane, US
Employees
275↑ 5% increase
Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other food allergies.
View company
Portola Pharmaceuticals
HQ
South San Francisco, US
Employees
324↑ 29% increase
Portola Pharmaceuticals is a biopharmaceutical company.
View company